CD4+T细胞Tim-3分子在急性期过敏性紫癜患儿外周血中的表达及其临床意义
The Expression and Clinical Significance of CD4+Tim-3+T Cell in Peripheral Blood for Acute Henoch Schonlein Purpura Patients
DOI: 10.12677/ACM.2018.86098, PDF,    科研立项经费支持
作者: 李宵霖, 陈 欧:山东大学护理学院,山东 济南;陈少杰, 王一彪:山东大学第二医院儿科,山东 济南
关键词: HSPTim-3血沉HSP Tim-3 Erythrocyte Sedimentation Rate
摘要: 目的:探讨Tim-3在急性期过敏性紫癜(Henoch Schonlein Purpura, HSP)患儿外周血CD4+细胞中的表达及其相关临床意义。方法:选取22名HSP急性期患儿及15名健康对照作为研究对象,流式细胞分析术分子检测各组研究对象外周血外周血CD4+Tim-3+T细胞比例。并分析该比例与相关临床表现的相关性。结果:HSP患儿急性期外周血CD4+ Tim-3+T细胞比例(3.03% ± 0.69%)下降较对照组(3.74% ± 0.62%)降低,二者比较结果有统计学意义(P < 0.05)。外周血CD4+Tim-3+T细胞比例与血沉水平呈负相关(r = −0.813, p < 0.05),与皮疹持续天数(r = −0.063; P > 0.05)、肾损害(r = −0.208; P > 0.05)、ASO (r = −0.057; P > 0.05)、补体C3水平(r = −0.029; P > 0.05)及患儿受损系统的个数(r = 0.166; P > 0.05)无相关性。结论:HSP急性期患儿外周血CD4+Tim-3+T细胞比例降低。Tim-3通路有可能参与HSP发病,该指标也许可以作为衡量HSP疾病诊断及病情活动的参考指标。
Abstract: Objective: To identify the expression and clinical significance of Tim-3 in CD4+ T cells in HSP acute patients. Methods: 22 HSP acute patients and 15 health cases took part in this research. The fre-quencies of CD4+Tim-3+ T cells in peripheral blood were detected by Flow cytometry. It also ana-lyzed the relationship between CD4+Tim-3+ T cells and clinical features. Results: The frequencies of CD4+Tim-3+ T cells were lower in acute HSP patients (3.03% ± 0.69%) than in healthy controls (3.74 ± 0.62%). The frequencies of CD4+Tim-3+ T cells were negative related with ESR in HSP acute patients (r = −0.813, p < 0.05), but had no correlation with rash duration in days (r = −0.063; P > 0.05), kidney lesions (r = −0.208; P > 0.05), ASO (r = −0.057; P > 0.05), C3 (r = −0.029; P > 0.05) and the numbers with lesion systems (r = 0.166; P > 0.05). Conclusion: The frequencies of CD4+Tim-3+ T cells in acute HSP acute patients reduced. The passage of Tim-3 maybe involved the onset of HSP.
文章引用:李宵霖, 陈少杰, 王一彪, 陈欧. CD4+T细胞Tim-3分子在急性期过敏性紫癜患儿外周血中的表达及其临床意义[J]. 临床医学进展, 2018, 8(6): 585-589. https://doi.org/10.12677/ACM.2018.86098

参考文献

[1] Yang, Y.H., Chuang, Y.H., Wang, L.C., Huang, H.Y., Gershwin, M.E. and Chiang, B.L. (2008) The Immunobiology of Henoch-Schonlein Purpura. Autoimmunity Reviews, 7, 179-184. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, O., Zhu, X.B., Ren, H., Wang, Y.B. and Sun, R.P. (2013) The Imbalance of Th17/Treg in Chinese Children with Henoch-Schonlein Purpura. International Immunopharmacology, 16, 67-71. [Google Scholar] [CrossRef] [PubMed]
[3] Gongalves Silva, I., Ruegg, L., Gibbs, B.F., Bardelli, M., Fruelwirth, A., Varani, L., et al. (2016) The Immune Receptor Tim-3 Acts as a Trafficker in a Tim-3/Galectin-9 Auto-crine Loop in Human Myeloid Leukemia Cells. Oncoimmunology, 5, e1195535. [Google Scholar] [CrossRef
[4] Horlad, H., Ohnishi, K., Ma, C., Fujwara, Y., Niino, D., Ohshima, K., et al. (2016) Tim-3 Expression in Lymphoma Cells Predicts Chemoresistance in Patients with Adult T-Cell Leukemia/Lymphoma. Oncology Letters, 12, 1519-1524. [Google Scholar] [CrossRef] [PubMed]
[5] Mills, J.A., Michel, B.A., Bloch, D.A., Calabrese, L.H., Hunder, G.G., Arend, W.P., et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Henoch Schonlein Purpura. Arthritis & Rheumatology, 33, 1114-1121. [Google Scholar] [CrossRef] [PubMed]
[6] Shi, F., Guo, X., Jiang, X., Zhou, P., Xiao, Y., Zhou, T., et al. (2012) Dysregulated Tim-3 Expression and Its Correlation with Imbalanced CD4 Helper T Cell Function in Ulcerative Colitis. Clinical Immunology, 145, 230-240. [Google Scholar] [CrossRef] [PubMed]
[7] Jones, R.B., Ndhlovu, L.C., Barbour, J.D., Sheth, P.M., Jha, A.R., et al. (2008) Tim-3 Expression Defines a Novel Population of Dysfunctional T Cells with Highly Elevated Frequencies in Progressive HIV-1 Infection. The Journal of Experimental Medicine, 205, 2763-2779. [Google Scholar] [CrossRef] [PubMed]
[8] 王培. Tim-3在外周血单个核细胞上的表达及其在类风湿关节炎高活动度患者中的病理意义[D]: [硕士学位论文]. 武汉: 华中科技大学, 2011.
[9] Namgoong, M.K., Lim, B.K. and Kim, J.S. (1997) Eosinophil Cationic Protein in Heoch-Schonlein Purpura and in IgA Nephropathy. Pediatric Neph-rology, 11, 703-706. [Google Scholar] [CrossRef] [PubMed]
[10] Del Vecchio, G.C., Penza, R., Altomare, M., Piacente, L., Aceto, G., Lassandro, G., et al. (2008) Cytokine Pattern and Endothelium Damage Markers in Henoch-Schonlein Purpura. Immunopharmacology and Immunotoxicology, 30, 623-629. [Google Scholar] [CrossRef] [PubMed]
[11] Davin, J.C., Pierard, G., Dechenne, C., Grossman, D., Nagy, J., Quacoe, M., et al. (1994) Possible Pathogenic Role of IgE in Henoch-Schonlein Purpura. Pediatric Nephrology, 8, 169-171.
[12] Li, Y.Y., Li, C.R., Wang, G.B., Yang, J. and Zu, Y. (2012) Investigation of the Change in CD4+ T Cell Subset in Children with Henoch-Schonlein Purpura. Rheumatology International, 32, 3785-3792. [Google Scholar] [CrossRef] [PubMed]
[13] Koguchi, K., Anderson, D.E., Yang, L., O’Connor, K.C., Kuchroo, V.K. and Hafler, D.A. (2006) Dysregulated T Cell Expression of TIM3 in Multiple Sclerosis. The Journal of Experimental Medicine, 203, 1413-1418. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, Y., Shu, Q., Gao, L., Hou, N., Zhao, D., Liu, X., et al. (2010) In-creased Tim-3 Expression on Peripheral Lymphocytes from Patients with Rheumatoid Arthritis Negatively Correlates with Disease Activity. Clinical Immunology, 137, 288-295. [Google Scholar] [CrossRef] [PubMed]
[15] Yuan, L.P., Ling, L. and Bo, H. (2012) T-Cell Immunoglobulin and Mucin-Domain-Containing Molecule-1 in Peripheral Blood Mononuclear Cells in Henoch-Schönlein Purpura. Indian Pediatrics, 49, 225-227. [Google Scholar] [CrossRef] [PubMed]